August 18, 2014
Schizophrenia is among the most severe forms of mental illness, yet some people with the disease are as happy as those in good physical and mental health according to a study led by researchers at the University of California, San Diego School of Medicine.
April 23, 2012
According to a new study, the neuron-killing pathology of Alzheimer’s disease (AD), which begins before clinical symptoms appear, requires the presence of both amyloid-beta (a-beta) plaque deposits and elevated levels of an altered protein called p-tau.
April 16, 2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardiovascular disease risk factors: high levels of inflammatory C-reactive protein (CRP) and plasma lipids or fats. The findings suggest the two cardiovascular…
April 29, 2014
A team of researchers investigating the genome of a healthy supercentenarian since 2011 has found many somatic mutations – permanent changes in cells other than reproductive ones – that arose during the woman’s lifetime. Led by Erik Sistermans and Henne Holstege from the VU University Medical Center in Amsterdam, the…
September 12, 2016
A longtime favorite of students, faculty and administrators alike, former University of California San Diego electrical and computer engineering professor Anthony V. Sebald passed away on July 11, 2016. He was 74 years old. For nearly 30 years, Sebald served the campus, the Jacobs School of Engineering and its Department…
February 2, 2023
From pandemics to health inequities, confronting future crises will look different — and that’s a good thing.
March 5, 2018
For the first time, an international team of scientists, led by researchers at University of California San Diego School of Medicine, have determined that an Alzheimer’s disease (AD) polygenic risk score can be used to correctly identify adults with mild cognitive impairment (MCI) who were only in their 50s. MCI…
July 19, 2022
With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.
August 23, 2021
Amyloid plaques found in the retinas of eyes may be an indicator of similar plaques in the brain, a hallmark of Alzheimer’s disease, and may provide a more visible biomarker for detecting disease risk.
November 23, 2021
A new study is showing how value choices are recorded in our brains. Researchers found that persistency allows value signals to be most effectively represented, or “coded,” across different areas of the brain, especially in a critical area within the cerebrum known as the retrosplenial cortex.
